Lv6
2090 积分 2023-12-05 加入
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
17天前
已完结
Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer
1个月前
已完结
Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer
1个月前
已完结
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception
1个月前
已完结
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Evaluation of contrast-enhanced mammography (CEM) in the preoperative staging of breast cancer: large-scale single center experience, update to 1005 cases
1个月前
已完结
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
1个月前
已完结
Basic FISH Techniques and Troubleshooting
1个月前
已完结
Ethical Governance of Artificial Intelligence in the Public Sector
皖公网安备34019202002308
